Jasper Therapeutics Inc
NASDAQ:JSPR
Jasper Therapeutics Inc
NASDAQ:JSPR
Price:
23.98 USD
0.25%
Market Closed
Updated:
May 29, 2024
Jasper Therapeutics Inc
Other Current Assets
|
Jasper Therapeutics Inc
Other Current Assets Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Other Current Assets Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Jasper Therapeutics Inc
NASDAQ:JSPR
|
Other Current Assets
$1.8m
|
CAGR 3-Years
93%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Other Current Assets
$4.6B
|
CAGR 3-Years
5%
|
CAGR 5-Years
21%
|
CAGR 10-Years
6%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Current Assets
$2.8B
|
CAGR 3-Years
14%
|
CAGR 5-Years
8%
|
CAGR 10-Years
10%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Current Assets
$2.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
-1%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Current Assets
$511.1m
|
CAGR 3-Years
15%
|
CAGR 5-Years
31%
|
CAGR 10-Years
31%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Current Assets
$414.9m
|
CAGR 3-Years
25%
|
CAGR 5-Years
18%
|
CAGR 10-Years
17%
|
See Also
What is Jasper Therapeutics Inc's Other Current Assets?
Other Current Assets
1.8m
USD
1.8m
USD
Based on the financial report for Dec 31, 2023, Jasper Therapeutics Inc's Other Current Assets amounts to 1.8m USD.
What is Jasper Therapeutics Inc's Other Current Assets growth rate?
Other Current Assets CAGR 3Y
93%
93%
Over the last year, the Other Current Assets growth was -30%. The average annual Other Current Assets growth rates for Jasper Therapeutics Inc have been 93% over the past three years .
You don't have any saved screeners yet
